GAD65 antibody isotypes and epitope recognition during the prediabetic process in siblings of children with type I diabetes

Clinical and Experimental Immunology

Volumn 136, Issue 1, 2004, Pages 120-128

  Hoppu, S ^a,b   Ronkainen, M S ^d   Kulmala, P ^c   Akerblom H K ^d   Knip, M ^a,b,d  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoantibodies; Epitope spreading; Glutamic acid decarboxylase; Isotype switching; Preclinical type I diabetes

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; ISOENZYME; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; RELATIVE;

ADOLESCENT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; EPITOPES; FEMALE; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MALE; PREDIABETIC STATE;

EID: 1842559613     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02416.x     Document Type: Article

References (35)

1. Castano LE, Eisenbarth GS. Type I diabetes: a chronic autoimmune disease of man, mouse and rat. Ann Rev Immunol 1990; 8:647-79.
2. Palmer JP. Predicting type I diabetes. Use of humoral immune markers. Diabetes Rev 1993; 1:104-15.
3. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298:167-9.
4. Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151-6.
5. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ. 64 000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 1990; 335:1357-60.
6. Sabbah E, Kulmala P, Veijola R et al. GAD65 antibodies in relation to other antibodies and genetic risk markers in children with newly diagnosed IDDM. J Clin Endocrinol Metab 1996; 81:2455-9.
7. Kulmala P, Savola K, Petersen JS et al. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. J Clin Invest 1998; 101:327-36.
8. r isoform of glutamic acid decarboxylase. Diabetes 1993; 42:631-6.
9. Vandewalle CL, Falorni A, Svanholm S, Lernmark A, Pipeleers DG, Gorus FK. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry. J Clin Endocrinol Metab 1995; 80:846-51.
10. Daw K, Powers AC. Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes 1995; 44:216-20.
11. Ujihara N, Daw K, Gianani R, Boel EYuL, Powers AC. Identification of glutamic acid decarboxylase autoantibody heterogenity and epitope regions in type I diabetes. Diabetes 1994; 43:968-75.
12. Richter W, Shi Y, Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 1993; 90:2832-6.
13. Falorni A, Ackefors M, Carlberg C et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 1996; 39:1091-8.
14. Sohnlein P, Muller M, Syren K et al. Epitope profiles of anti-glutamate decarboxylase reactive sera are titer-related, but not disease specific and identify EP-1 as a dominant target of autoantibody response. Diabetologia 2000; 43:210-7.
15. Bonifacio E, Lampasona V, Bernasconi L, Ziegler AG. Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type I diabetes. Diabetes 2000; 49:202-8.
16. Toellner KM, Luther SA, Sze DM et al. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med 1998; 187:1193-204.
17. Petersen JS, Kulmala P, Clausen JT, Knip M, Dyrberg T and the Childhood Diabetes in Finland Study Group. Progression to type I diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase. Clin Immunol 1999; 2:276-81.
18. Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 26:1185-8.
19. Pilström B, Björk L, Böhme J. Demonstration of Th1 cytokine profile in the late phase of NOD insulitis. Cytokine 1995; 8:806-14.
20. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996; 8:837-42.
21. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
22. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. Epidemiology of childhood diabetes mellitus in Finland - background of a nationwide study of Type I (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:70-6.
23. Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M. Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. Diabetologia 1998; 41:1293-7.
24. Verge CF, Stenger D, Bonifacio E et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type I diabetes. Combinatorial islet autoantibody workshop. Diabetes 1998; 47:1857-66.
25. Bonifacio E, Scirpoli M, Kredel K, Füchtenbusch M, Ziegler AG. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. J Immunol 1999; 163:525-32.
26. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2:1279-82.
27. Palmer JP, Clemons P, Lyen K, Tatpati O, Rahgu PK, Paquette TL. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222:1337-9.
28. Savola K, Bonifacio E, Sabbah E et al. IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 1998; 41:424-9.
29. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R. Childhood Diabetes in Finland Study Group. New susceptibility haplotype for type I diabetes. Lancet 1989; 2:299-302.
30. Albert ED, Mayr WR (eds) Nomenclature for factors of the HLA system. Histocompatibility testing. Berlin: Springer-Verlag, 1984: 4-8.
31. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990; 300:230-5.
32. Falorni A, Gambelunghe G, Forini F et al. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 2000; 85:309-16.
33. Couper JJ, Harrison LC, Aldis JJE, Colman P, Honeyman MC, Ferrante A. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes. Hum Immunol 1998; 59:493-9.
34. Hawa MI, Fava D, Medici F et al. Antibodies to IA-2 and GAD65 in type I and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care 2000; 23:228-33.
35. Lohmann T, Hawa M, Leslie RD, Lane R, Picard J, Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and Type I diabetes mellitus. Lancet 2000; 356:31-5.